Integer (ITGR) Stock Price, News & Analysis

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Integer in the last twelve months. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" ITGR shares.
View ITGR analyst ratings or view top-rated stocks.

6 Wall Street analysts have issued 1 year price objectives for Integer's stock. Their ITGR share price targets range from $88.00 to $139.00. On average, they anticipate the company's share price to reach $120.50 in the next twelve months. This suggests a possible upside of 1.7% from the stock's current price.
View analysts price targets for ITGR or view top-rated stocks among Wall Street analysts.

Integer's stock was trading at $99.08 at the beginning of the year. Since then, ITGR stock has increased by 19.6% and is now trading at $118.53.
View the best growth stocks for 2024 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 25th 2024.
View our ITGR earnings forecast.

Integer will be holding an earnings conference call on Thursday, April 25th at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 609-800-9909 with passcode "9252310".

Integer Holdings Co. (NYSE:ITGR) announced its quarterly earnings results on Thursday, February, 15th. The medical equipment provider reported $1.39 earnings per share for the quarter, topping the consensus estimate of $1.34 by $0.05. The medical equipment provider had revenue of $413.15 million for the quarter, compared to analysts' expectations of $409.04 million. Integer had a trailing twelve-month return on equity of 10.80% and a net margin of 5.68%. Integer's revenue was up 10.9% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.11 earnings per share.

ETFs with the largest weight of Integer (NYSE:ITGR) stock in their portfolio include Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Equipment ETF (XHE), Invesco S&P SmallCap Momentum ETF (XSMO), AlphaMark Actively Managed Small Cap ETF (SMCP), SPDR S&P 600 Small Cap Growth ETF (SLYG), Vanguard S&P Small-Cap 600 Growth ETF (VIOG), Xtrackers S&P SmallCap 600 ESG ETF (SMLE) and Global X Aging Population ETF (AGNG).

Integer issued an update on its FY 2024 earnings guidance on Friday, February, 16th. The company provided EPS guidance of 5.010-5.430 for the period, compared to the consensus earnings per share estimate of 5.450. The company issued revenue guidance of $1.7 billion-$1.8 billion, compared to the consensus revenue estimate of $1.8 billion.

40 employees have rated Integer Chief Executive Officer Joseph Dziedzic on Glassdoor.com. Joseph Dziedzic has an approval rating of 86% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Integer investors own include Abbott Laboratories (ABT), Pfizer (PFE), Procter & Gamble (PG), Gilead Sciences (GILD), Coca-Cola (KO), AT&T (T), AbbVie (ABBV), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and General Mills (GIS).

Integer's stock is owned by many different institutional and retail investors. Top institutional shareholders include Congress Asset Management Co. MA (1.36%), Park Avenue Securities LLC (0.02%), Guidance Capital Inc. (0.01%) and Canandaigua National Bank & Trust Co. (0.01%). Insiders that own company stock include Anthony W Borowicz, Bill R Sanford, Bill R Sanford, Carter Houghton, Donald J Spence, Jean M Hobby, Joseph F Flanagan, Joseph W Dziedzic and Pamela G Bailey.
View institutional ownership trends.

Shares of ITGR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.